Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Joly

Showing results (171-180 of 347) with videos related to

Pageof 35
Sort By:
Clinical Genitourinary Cancer|July 16, 2018
Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic TherapiesAngeline Denouel, Natacha Heutte, Bernard Escudier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2011
Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie GynécologiqueDenis Querleu, François Planchamp, Fabrice Narducci, et al.
Radiation Oncology (London, England)|January 29, 2025
Neurocognitive impact of different irradiation modalities for patients with grade I-II skull base meningioma: a prospective multi-arm cohort study (CANCER COG)Paul Lesueur, Florence Joly, Benedicte Clarisse, et al.
British Journal of Cancer|December 14, 2023
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancerDanka Sinikovic Zebic, Angelina Tjokrowidjaja, Katherine Elizabeth Francis, et al.
BMC Cancer|July 5, 2020
Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trialLidia Delrieu, Amélie Anota, Olivier Trédan, et al.
Radiation Oncology (London, England)|April 29, 2025
Correction: Neurocognitive impact of different irradiation modalities for patients with grade I-II skull base meningioma: a prospective multi-arm cohort study (CANCER COG)Paul Lesueur, Florence Joly, Benedicte Clarisse, et al.
International Journal of Cancer|July 29, 2014
Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: an ex vivo experiment in human serous ovarian carcinomaStéphanie Lheureux, Monique N'Diaye, Cécile Blanc-Fournier, et al.
The Lancet. Oncology|October 17, 2017
Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trialTomasz M Beer, Sebastien J Hotte, Fred Saad, et al.
Bulletin Du Cancer|January 30, 2026
[Recommendations for clinical practice Nice-Saint Paul de Vence 2024-2025: Management of advanced/relapsing endometrial cancer]Lauriane Eberst, Corinne Jeanne, Guillaume Bataillon, et al.
Psycho-Oncology|April 30, 2022
Impact of creative art therapy on fatigue and quality of life in patients treated for localized breast cancer: A randomized studyFlorence Joly, David Pasquier, Christelle Levy, et al.
Pageof 35

Showing results (171-180 of 347) with videos related to

Sort By:
Pageof 35
Clinical Genitourinary Cancer|July 16, 2018
Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic TherapiesAngeline Denouel, Natacha Heutte, Bernard Escudier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2011
Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie GynécologiqueDenis Querleu, François Planchamp, Fabrice Narducci, et al.
Radiation Oncology (London, England)|January 29, 2025
Neurocognitive impact of different irradiation modalities for patients with grade I-II skull base meningioma: a prospective multi-arm cohort study (CANCER COG)Paul Lesueur, Florence Joly, Benedicte Clarisse, et al.
British Journal of Cancer|December 14, 2023
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancerDanka Sinikovic Zebic, Angelina Tjokrowidjaja, Katherine Elizabeth Francis, et al.
BMC Cancer|July 5, 2020
Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trialLidia Delrieu, Amélie Anota, Olivier Trédan, et al.
Radiation Oncology (London, England)|April 29, 2025
Correction: Neurocognitive impact of different irradiation modalities for patients with grade I-II skull base meningioma: a prospective multi-arm cohort study (CANCER COG)Paul Lesueur, Florence Joly, Benedicte Clarisse, et al.
International Journal of Cancer|July 29, 2014
Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: an ex vivo experiment in human serous ovarian carcinomaStéphanie Lheureux, Monique N'Diaye, Cécile Blanc-Fournier, et al.
The Lancet. Oncology|October 17, 2017
Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trialTomasz M Beer, Sebastien J Hotte, Fred Saad, et al.
Bulletin Du Cancer|January 30, 2026
[Recommendations for clinical practice Nice-Saint Paul de Vence 2024-2025: Management of advanced/relapsing endometrial cancer]Lauriane Eberst, Corinne Jeanne, Guillaume Bataillon, et al.
Psycho-Oncology|April 30, 2022
Impact of creative art therapy on fatigue and quality of life in patients treated for localized breast cancer: A randomized studyFlorence Joly, David Pasquier, Christelle Levy, et al.
Pageof 35